Comparable trends were observed in the VCU-ART studies [5,6], where IL-1 blockade reduced ventricular remodeling after MI, and in observational cohorts linking resistin to adverse cardiac remodeling and mortality. This evidence concerns the gene IL1B and myocardial infarction.